ENFLONSIA is a long-acting monoclonal antibody designed to shield infants through a typical five-month RSV season with a single, fixed dose
The CE Mark builds on the company’s ISO 13485 certification, further strengthening confidence in the platform's safety, quality and performance
The event marks a significant push into South Korea’s rapidly expanding bio-health ecosystem
Dr Desai argued that the sector is undergoing a structural acceleration in how quickly science turns into treatments
The upcoming multi-center, multinational Phase 1 study will evaluate safety, tolerability, pharmacokinetics, and early signs of efficacy
CDSCO-approved therapy enters India’s fast-growing post-patent GLP-1 market with fully integrated API, formulation and pen manufacturing
API-first, DPI-driven DDRS platform aims to modernize drug and medical device regulation in India
Policy, regulations, AI and CRDMO take centre stage at the flagship event of the Department of Pharmaceuticals
Panacea Biotec receives LoA from CMSS
Subscribe To Our Newsletter & Stay Updated
